Annual report
3154.TEDINET S100Z035
Period2020-07-01 → 2021-06-30
Filed2026-09-03
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100MIHH. Amended by S100Z0AR (2026-09-03).
Key figures · 152
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥246.8bn | 2020-07-01 → 2021-06-30 | Cons. | Net sales |
| Revenue | ¥210.4bn | 2019-07-01 → 2020-06-30 | Cons. | Net sales |
| Revenue | ¥197.7bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥168.1bn | 2017-07-01 → 2018-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥162.7bn | 2016-07-01 → 2017-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.7bn | 2020-07-01 → 2021-06-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2019-07-01 → 2020-06-30 | Cons. | Operating income |
| Ordinary income | ¥3.2bn | 2020-07-01 → 2021-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.6bn | 2019-07-01 → 2020-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2017-07-01 → 2018-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2016-07-01 → 2017-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.2bn | 2020-07-01 → 2021-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.3bn | 2019-07-01 → 2020-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.1bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥951m | 2019-07-01 → 2020-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥70m | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥742m | 2017-07-01 → 2018-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥863m | 2016-07-01 → 2017-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.1bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss |
| Net income | ¥951m | 2019-07-01 → 2020-06-30 | Cons. | Profit loss |
| Total assets | ¥84.4bn | at 2021-06-30 | Cons. | Assets |
| Total assets | ¥70.0bn | at 2020-06-30 | Cons. | Assets |
| Total assets | ¥62.0bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥53.7bn | at 2018-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥47.5bn | at 2017-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥68.6bn | at 2021-06-30 | Cons. | Liabilities |
| Total liabilities | ¥56.1bn | at 2020-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥15.8bn | at 2021-06-30 | Cons. | Net assets |
| Net assets / equity | ¥13.9bn | at 2020-06-30 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2019-06-30d | Cons. | Net assets |
| Net assets / equity | ¥10.6bn | at 2018-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥9.8bn | at 2017-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.6bn | at 2021-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.5bn | at 2020-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.6bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.5bn | at 2020-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.3bn | at 2019-06-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2018-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.0bn | at 2017-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥6.8bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2019-07-01 → 2020-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.1bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥723m | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.4bn | 2016-07-01 → 2017-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥4.6bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥138m | 2019-07-01 → 2020-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥1.7bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥308m | 2016-07-01 → 2017-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥1.9bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥788m | 2019-07-01 → 2020-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.3bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.2bn | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.6bn | 2016-07-01 → 2017-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥94.81 | 2020-07-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.66 | 2019-07-01 → 2020-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.21 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.12 | 2017-07-01 → 2018-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.37 | 2016-07-01 → 2017-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥94.15 | 2020-07-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.6 | 2019-07-01 → 2020-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥727.12 | at 2021-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥636.71 | at 2020-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥582.16 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥546.64 | at 2018-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥503.73 | at 2017-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 18.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.8% | at 2020-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.5% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.8% | at 2018-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.7% | at 2017-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 13.9% | 2020-07-01 → 2021-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2019-07-01 → 2020-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -0.6% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2017-07-01 → 2018-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.0% | 2016-07-01 → 2017-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,002 | at 2021-06-30 | Cons. | Number of employees |
| Employees | 1,926 | at 2020-06-30 | Cons. | Number of employees |
| Employees | 1,680 | at 2019-06-30d | Cons. | Number of employees |
| Employees | 1,449 | at 2018-06-30d | Cons. | Number of employees |
| Employees | 1,413 | at 2017-06-30d | Cons. | Number of employees |
| Revenue | ¥2.4bn | 2020-07-01 → 2021-06-30 | Standalone | Net sales |
| Revenue | ¥2.2bn | 2019-07-01 → 2020-06-30 | Standalone | Net sales |
| Revenue | ¥2.0bn | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.8bn | 2017-07-01 → 2018-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.6bn | 2016-07-01 → 2017-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥436m | 2020-07-01 → 2021-06-30 | Standalone | Operating income |
| Operating income | ¥210m | 2019-07-01 → 2020-06-30 | Standalone | Operating income |
| Ordinary income | ¥703m | 2020-07-01 → 2021-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥486m | 2019-07-01 → 2020-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥573m | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥424m | 2017-07-01 → 2018-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥361m | 2016-07-01 → 2017-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥687m | 2020-07-01 → 2021-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥882m | 2019-07-01 → 2020-06-30 | Standalone | Income before income taxes |
| Net income | ¥663m | 2020-07-01 → 2021-06-30 | Standalone | Profit loss |
| Net income | ¥853m | 2019-07-01 → 2020-06-30 | Standalone | Profit loss |
| Net income | −¥614m | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥48m | 2017-07-01 → 2018-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥349m | 2016-07-01 → 2017-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥21.5bn | at 2021-06-30 | Standalone | Assets |
| Total assets | ¥21.5bn | at 2020-06-30 | Standalone | Assets |
| Total assets | ¥18.1bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥17.8bn | at 2018-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥13.7bn | at 2017-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥13.4bn | at 2021-06-30 | Standalone | Liabilities |
| Total liabilities | ¥13.8bn | at 2020-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥8.1bn | at 2021-06-30 | Standalone | Net assets |
| Net assets / equity | ¥7.6bn | at 2020-06-30 | Standalone | Net assets |
| Net assets / equity | ¥6.8bn | at 2019-06-30d | Standalone | Net assets |
| Net assets / equity | ¥5.5bn | at 2018-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.5bn | at 2017-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥460m | at 2021-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥390m | at 2020-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥30.43 | 2020-07-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.16 | 2019-07-01 → 2020-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-28.16 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.45 | 2017-07-01 → 2018-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.92 | 2016-07-01 → 2017-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥30.22 | 2020-07-01 → 2021-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥39.12 | 2019-07-01 → 2020-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥21 | 2020-07-01 → 2021-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2019-07-01 → 2020-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2017-07-01 → 2018-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2016-07-01 → 2017-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥372.32 | at 2021-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥350.09 | at 2020-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥310.69 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥283.13 | at 2018-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥281.05 | at 2017-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 37.8% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.5% | at 2020-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.4% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.9% | at 2018-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.9% | at 2017-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.4% | 2020-07-01 → 2021-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2019-07-01 → 2020-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -10.0% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.9% | 2017-07-01 → 2018-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2016-07-01 → 2017-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 21,789,724 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,789,724 | at 2020-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,789,724 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,453,536 | at 2018-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,484,512 | at 2017-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 74 | at 2021-06-30 | Standalone | Number of employees |
| Employees | 73 | at 2020-06-30 | Standalone | Number of employees |
| Employees | 66 | at 2019-06-30d | Standalone | Number of employees |
| Employees | 54 | at 2018-06-30d | Standalone | Number of employees |
| Employees | 51 | at 2017-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2020-07-01 → 2021-06-30 | ¥3.4bn |
| Reconciling Itemsreconciling | depreciation | 2020-07-01 → 2021-06-30 | ¥305m |
| Reconciling Itemsreconciling | segment assets | at 2021-06-30 | ¥38.1bn |
| Reconciling Itemsreconciling | segment profit | 2020-07-01 → 2021-06-30 | −¥6.1bn |
| Medical Equipment Salesreportable segment | capex | 2020-07-01 → 2021-06-30 | ¥391m |
| Medical Equipment Salesreportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥161m |
| Medical Equipment Salesreportable segment | employees | at 2021-06-30 | 1480 pure |
| Medical Equipment Salesreportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥241.2bn |
| Medical Equipment Salesreportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥241.2bn |
| Medical Equipment Salesreportable segment | segment assets | at 2021-06-30 | ¥45.2bn |
| Medical Equipment Salesreportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥8.1bn |
| Nursing Welfarereportable segment | capex | 2020-07-01 → 2021-06-30 | ¥421m |
| Nursing Welfarereportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥246m |
| Nursing Welfarereportable segment | employees | at 2021-06-30 | 177 pure |
| Nursing Welfarereportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥5.6bn |
| Nursing Welfarereportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥5.6bn |
| Nursing Welfarereportable segment | segment assets | at 2021-06-30 | ¥1.1bn |
| Nursing Welfarereportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥692m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-07-01 → 2021-06-30 | ¥813m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-07-01 → 2021-06-30 | ¥408m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-07-01 → 2021-06-30 | ¥246.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-07-01 → 2021-06-30 | ¥246.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-06-30 | ¥46.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-07-01 → 2021-06-30 | ¥8.8bn |
| Reconciling Itemsreconciling | capex | 2019-07-01 → 2020-06-30 | ¥2.1bn |
| Reconciling Itemsreconciling | depreciation | 2019-07-01 → 2020-06-30 | ¥312m |
| Reconciling Itemsreconciling | revenue | 2019-07-01 → 2020-06-30 | −¥302,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2019-07-01 → 2020-06-30 | −¥302,000 |
| Reconciling Itemsreconciling | segment assets | at 2020-06-30 | ¥26.3bn |
| Reconciling Itemsreconciling | segment profit | 2019-07-01 → 2020-06-30 | −¥6.2bn |
| Medical Equipment Salesreportable segment | capex | 2019-07-01 → 2020-06-30 | ¥612m |
| Medical Equipment Salesreportable segment | depreciation | 2019-07-01 → 2020-06-30 | ¥150m |
| Medical Equipment Salesreportable segment | revenue | 2019-07-01 → 2020-06-30 | ¥205.4bn |
| Medical Equipment Salesreportable segment | revenue external | 2019-07-01 → 2020-06-30 | ¥205.4bn |
| Medical Equipment Salesreportable segment | segment assets | at 2020-06-30 | ¥42.7bn |
| Medical Equipment Salesreportable segment | segment profit | 2019-07-01 → 2020-06-30 | ¥6.8bn |
| Nursing Welfarereportable segment | capex | 2019-07-01 → 2020-06-30 | ¥223m |
| Nursing Welfarereportable segment | depreciation | 2019-07-01 → 2020-06-30 | ¥212m |
| Nursing Welfarereportable segment | revenue | 2019-07-01 → 2020-06-30 | ¥5.0bn |
| Nursing Welfarereportable segment | revenue external | 2019-07-01 → 2020-06-30 | ¥5.0bn |
| Nursing Welfarereportable segment | revenue intersegment | 2019-07-01 → 2020-06-30 | ¥302,000 |
| Nursing Welfarereportable segment | segment assets | at 2020-06-30 | ¥937m |
| Nursing Welfarereportable segment | segment profit | 2019-07-01 → 2020-06-30 | ¥544m |
| Total Of Reportable Segments And Otherssegment total | capex | 2019-07-01 → 2020-06-30 | ¥836m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2019-07-01 → 2020-06-30 | ¥362m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2019-07-01 → 2020-06-30 | ¥210.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2019-07-01 → 2020-06-30 | ¥210.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2019-07-01 → 2020-06-30 | ¥302,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2020-06-30 | ¥43.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2019-07-01 → 2020-06-30 | ¥7.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,590
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 3 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 3 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 2.723 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 2.531 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.831 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 2.380 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 2.753 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.322 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.450 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.331 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.372 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.747 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 1480 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 541 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E22995-000NursingWelfareReportableSegmentsMember | 177 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E22995-000NursingWelfareReportableSegmentsMember | 56 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 345 | |
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | 144 | |
| Number of employees | CurrentYearInstant | 2002 | |
| Average number of temporary workers | CurrentYearInstant | 741 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 74 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 3 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 40.9 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 4.8 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 6867655 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 74 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 3 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 74 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 3 | |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 4171735000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 391206000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E22995-000NursingWelfareReportableSegmentsMember | 421472000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_CorporateSharedMember | 3359056000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 21789724 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 21925104 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 21789724 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 21925104 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 13 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 12 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 144 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 31 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 24 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 20566 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 20790 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 10580 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 470 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 69714 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |